Facebook
Twitter
LinkedIn
Forward5th Annual Sepsis Symposium- Virtual Meeting
IMPORTANT BROWSER INFORMATION |
|---|
This site will not work on Internet Explorer 8. Please use: |
This knowledge-based conference will feature national experts on both sepsis and COVID-19. Attendees will gain a better understanding of the short and long term impacts of sepsis and current research priorities in this field. Wellspan, a recipient of NQIs prestigious John M. Eisenberg Patient Safety and Quality Award will share how their multi-hospital system operational approach improved over sepsis care and outcomes related to sepsis.
Sessions will be offered on the science and clinical aspects of COVID-19, including a focus on clinical presentation and management. A presentation will include a comprehensive update on recent clinical trials.
This program is free to all Jefferson and Mainline Health employees.
Successful Completion
Physicians, Nurses, Other Healthcare Providers
To successfully complete this activity, the required evaluation must be completed no later than Sunday, November 8, 2020. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
Pharmacists
To successfully complete this activity, the required evaluation must be completed no later than Saturday, October 24, 2020. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
Sponsorship/Commercial Support
This educational activity received commercial support from the Mountain Laurel Risk Retention Group.
Target Audience
This course is designed for all physicians, nurse practitioners, pharmacists, nurses, and physician assistants.
Learning Objectives
- Differentiate the clinical manifestations of a mild presentation of COVID-19 vs the progressive presentation to viral sepsi
- Identify how the current state of the COVID-19 pandemic, disease burden, and distribution, presents a significant and prolonged challenge for healthcare providers and systems.
- Analyze clinical presentation and treatment pitfalls of sepsis.
- Examine the latest developments and efficacy in the treatment of COVID.
- Evaluate how a remote monitoring platform for tracking indicators of sepsis can improve timelines and reduce variation of care with the goal of reducing sepsis related morbidity and mortality and healthcare costs related to sepsis.
- Recognize how the acute clinical course of sepsis can impact quality of life after hospital discharge, and long term functional status.
- PA patient safety and nursing pharmacology credits are offered.
Preliminary Program Agenda & Learning Objectives
This CE activity is a live virtual meeting. Instructions for accessing the course will be emailed to registrants prior to the start of the activity.
Panels & Featured Speakers
| Wellspan Health Panel |
| Steven Delaveris, DO |
| Emily Edleblute, MS, RN |
| Angela Mayes BSN, RN |
| Sagar Sinha, MD |
| Salvatore Di Somma MD |
| Hassan Al Thani MD |
| Prabath Nanayakkara MD |
| Stainislaw Stawicki MD |
| Pushpa Sharma MD |
| Featured Speakers |
| Anna Marie Chang, MD |
| Hallie Prescott, MD |
| David Oxman, MD |
| David Gaieski, MD |
| Jason Goldman, MD |
| Munish Goyal,MD |
| Nicholas Johnson, MD |
Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any relevant financial relationships with ACCME defined commercial interest entities within the past 12 months. Any conflict of interests have been resolved prior to this educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
Planning Committee
The following planning committee members have no conflicts of interest to disclose.
David Gaieski, MD-Activity Director
Joyce Stout, MPA, RN, CPHQ
Cindy Hou, DO
Carol Kelly, MSN, RN
Bernadette Cabry, MSH, RN
Karen Ryan, MSN, RN
Jeannine Girolamo, MSN, RN
Therese McGurkin, MSN, RN
Jerin Juby, MS, RT
Planner Disclosure
Glen Oettinger, PharmD, BCPS
Consultant, Scientific Advisor, Product Speaker Bureau for Janssen Pharmaceuticals
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physicians: This educational activity is designated for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 4.25 nursing contact hours.
Pharmacists: This knowledge-based continuing education activity is designated for 4.25 contact hours of continuing education credit.
Other Healthcare Professionals: This educational activity is designated for 4.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Other Credits
PA Patient Safety and Risk Credit: The entire agenda for this activity qualifies for 4.00 PA Patient Safety and Risk credits.
Nursing Pharmacotherapeutic Credit: 1.92 nursing pharmacotherapeutic credits offered. The following sessions qualify:
Bacterial Sepsis Case Discussion/Q&A
Hallie Prescott MD and Munish Goyal MD
Is it COVID or is it Sepsis?/Q&A
Dave Oxman MD and David Gaieski MD
Overview of Drug Therapies and Therapeutic Options for COVID-19/Q&A
Jason Goldman, MD
Available Credit
- 4.25 ACPE
- 4.25 AMA PRA Category 1 Credit™
- 4.25 Attendance
- 4.25 CNE
- 4.00 Patient Safety
Price
| Profession/ Affiliation | Registration Fee |
|---|---|
| Non- Jefferson Healthcare Professional | $50.00 |
| Jefferson Health Professional | Complimentary: pre-registration required |
| Main Line Health Professional | Complimentary -Please email : LevyP@MLHS.ORG to receive code. |
| HOW TO REGISTER |
|---|
IMPORTANT DEADLINES
To register online, you must have a CPD @ JeffLearn account.
|
Recording and Photography Strictly Prohibited
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity. No credits or refund will be issued.